(+)-Pulegone

(+)-pulegone is a lipid of Prenol Lipids (PR) class. The involved functions are known as Excretory function, conjugation, Competitive inhibition, radiochemical and Synthesis. (+)-pulegone often locates in Microsomes. The associated genes with (+)-Pulegone are 4S-limonene synthase.

Cross Reference

Introduction

To understand associated biological information of (+)-Pulegone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with (+)-Pulegone?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (+)-Pulegone

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Endophthalmitis D009877 12 associated lipids
Uveitis, Posterior D015866 5 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with (+)-Pulegone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with (+)-Pulegone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with (+)-Pulegone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with (+)-Pulegone?

There are no associated biomedical information in the current reference collection.

What genes are associated with (+)-Pulegone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with (+)-Pulegone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with (+)-Pulegone

Download all related citations
Per page 10 20 50 100 | Total 208
Authors Title Published Journal PubMed Link
Segev D et al. Chemical and morphological diversity in wild populations of Mentha longifolia in Israel. 2012 Chem. Biodivers. pmid:22422525
Chen XW et al. Herbal bioactivation, molecular targets and the toxicity relevance. 2011 Chem. Biol. Interact. pmid:21459083
Madyastha KM and Moorthy B Pulegone mediated hepatotoxicity: evidence for covalent binding of R(+)-[14C]pulegone to microsomal proteins in vitro. 1989 Chem. Biol. Interact. pmid:2691105
Li F et al. Profiling the reactive metabolites of xenobiotics using metabolomic technologies. 2011 Chem. Res. Toxicol. pmid:21469730
Gan J et al. Dansyl glutathione as a trapping agent for the quantitative estimation and identification of reactive metabolites. 2005 Chem. Res. Toxicol. pmid:15892584
Zhou SF et al. Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update. 2007 Curr. Drug Metab. pmid:17691916
Souza R et al. Gastroprotective activity of α-terpineol in two experimental models of gastric ulcer in rats. 2011 Daru pmid:22615669
Khojasteh-Bakht SC et al. Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: evidence for formation of a furan epoxide. 1999 Drug Metab. Dispos. pmid:10220485
Chen LJ et al. Metabolism of (R)-(+)-pulegone in F344 rats. 2001 Drug Metab. Dispos. pmid:11717176
Thulasiram HV et al. Effect of ring size in R-(+)-pulegone-mediated hepatotoxicity: studies on the metabolism of R-(+)-4-methyl-2-(1-methylethylidene)-cyclopentanone and DL-camphorone in rats. 2001 Drug Metab. Dispos. pmid:11353750
Chen LJ et al. Comparative disposition of (R)-(+)-pulegone in B6C3F1 mice and F344 rats. 2003 Drug Metab. Dispos. pmid:12814966
Thomassen D et al. Partial characterization of biliary metabolites of pulegone by tandem mass spectrometry. Detection of glucuronide, glutathione, and glutathionyl glucuronide conjugates. 1991 Sep-Oct Drug Metab. Dispos. pmid:1686249
Chen LJ et al. Metabolism of (R)-(+)-menthofuran in Fischer-344 rats: identification of sulfonic acid metabolites. 2003 Drug Metab. Dispos. pmid:12975329
Gordon WP et al. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran. 1987 Sep-Oct Drug Metab. Dispos. pmid:2891472
Thulasiram HV et al. Role of C-5 chiral center in R-(+)-pulegone-mediated hepatotoxicity: metabolic disposition and toxicity of 5, 5-dimethyl-2-(1-Methylethylidene)-cyclohexanone in rats. 2000 Drug Metab. Dispos. pmid:10859158
Inoue K et al. A trapping method for semi-quantitative assessment of reactive metabolite formation using [35S]cysteine and [14C]cyanide. 2009 Drug Metab. Pharmacokinet. pmid:19571436
Nelson SD Mechanisms of the formation and disposition of reactive metabolites that can cause acute liver injury. 1995 Drug Metab. Rev. pmid:7641574
de Cerqueira SV et al. R(+)-pulegone impairs Ca²+ homeostasis and causes negative inotropism in mammalian myocardium. 2011 Eur. J. Pharmacol. pmid:22004607
Amiri H Essential oils composition and antioxidant properties of three thymus species. 2012 Evid Based Complement Alternat Med pmid:21876714
Rossi YE et al. Molecular response of Musca domestica L. to Mintostachys verticillata essential oil, (4R)+-pulegone and menthone. 2012 Fitoterapia pmid:22155595